A database for life science partnering

Find the companies already looking for an asset like yours

Build a focused target list of companies that already in-license in your area. Read what each one is looking for before you decide who to contact.

Get a free partnering snapshot See how it works

Oncology therapeuticsMUnited States

Keywords

OncologyADCSolid TumoursAntibody

Company notes

Geographic focus: North America and Europe, open to Asia-Pacific originators.
Therapeutic focus: Solid tumours, with priority in breast, lung, and gastrointestinal cancers.
In-licensing strategy: Actively seeking assets to expand the oncology pipeline, open to regional or global rights and to co-development structures.
Modality of interest: ADCs and bispecific antibodies. Small molecules not of interest.
Stage of interest: IND-ready to Phase 2.

2 contacts

2,500+

In-licensing companies

4,000+

Verified BD contacts

Maintained by practitioners, updated weekly

How it works

Four things the platform does

Biocontacts is organised around one question: which companies want to bring in an asset like yours, and who decides. Everything below follows from that.

Filter the way a target list actually gets scoped

Search by company type, keywords across therapeutic area, indication, and modality, preferred stage of development, company size, and location, with include and exclude filters on region. The filters match how a BD team narrows a list, so you are not translating your question into someone else's categories first.

Potential partners

184 companies

Company type: Biotech/Pharma
Company location: Excluding United States
Company keywords: OncologyADCSolid tumours
Preferred stage of development: PreclinicalEarly Clinical
Company size: Mid-sizeLarge

Pre-qualify

Read what a company wants before you write to them

Every profile records stated in-licensing interests: therapeutic focus, modalities, stage preference, and partnering notes taken from our own meetings with that company. You can rule a company in or out before spending a credit on a contact.

Mid-size oncology developer

OncologyADCSolid tumoursEarly Clinical

Actively seeking preclinical to early clinical ADC assets in solid tumours. Prefers Asia-Pacific and European originators. Last confirmed at a partnering meeting.

Build

Keep a target list, and take it with you

Save companies to named target lists as you search, then export to Excel for your CRM or outreach sequence. One login covers your whole team, and lists are shared across it.

Target list: ADC partners

4 targets

Large pharma, JapanPhase 1

Mid-size biotech, GermanyPreclinical

Large pharma, United StatesPhase 2

Mid-size biotech, SingaporeEarly Clinical

Export to Excel

Reach

Contact the person who handles in-licensing

Unlock verified contacts in business development, external innovation, and search and evaluation roles. Each profile carries name, job title, company, email, therapeutic focus, and LinkedIn where available. If an email bounces, tell us and we refund the credit plus one more.

Head of Business Development

Mid-size oncology developer

••••••@••••••.comUnlock for 1 credit

Therapeutic focus: Oncology, solid tumours

Who it is for

Whether you are building a first target list or moving into a region you have not worked in, the starting point is the same: companies that already in-license in your area.

Technology transfer offices

You have IP ready to license and need to know which companies take university-stage assets in your field.

Find industry partners

Teams starting business development

A first target list with no existing network to draw on. Start from companies that already in-license in your area rather than a conference attendee list.

Build your first list

Teams expanding into new regions

You know your home market. Filter by headquarters location to find in-licensing companies where you have not worked before.

Search a new region

Assets ready to out-license

A late-stage asset and a defined partnering profile. Search by stage preference to find companies whose stated interests match what you have.

Search for licensees

Where the data comes from

Maintained by people who use it daily

Biocontacts is built and maintained alongside JustPartnering, a life sciences business development and licensing consultancy that has been working since 2007. We run 300+ face-to-face partnering meetings a year, and what companies tell us about their in-licensing interests goes into the platform.

The rest comes from company partnering documents and from emailing the companies listed to confirm their current interests. The platform is updated weekly, and contact records are re-verified as people move roles.

More on how the data is built and verified

Free partnering snapshot

See who is partnering in your area before you subscribe

Tell us your therapeutic areas, indications, or modalities. We run the search ourselves and send you a PDF covering:

How many companies match your focus
A breakdown by region and company size
The keywords and search terms we used on your behalf
The total number of partners you could reach through Biocontacts

Request your snapshot

Five fields. We come back within 2 business days.

What a search looks like

A walkthrough, on your own therapeutic area

A search usually takes four steps: set the therapeutic and modality filters, narrow by stage and region, scan the matching profiles for stated interests, then save the ones worth approaching to a target list and unlock contacts only for those.

We would rather show you that against your own asset than a generic example. Book a call and we will run it live.

Book a live demo

A search, step by step

4 steps

Set filters
Therapeutic area, modality, and stage.
Narrow further
Company size and headquarters location.
Scan profiles
Read each company's stated interests.
Save and unlock
Add the fits to a target list, then unlock only those contacts.

Common questions

What is Biocontacts?

Biocontacts is a searchable database of life science companies that in-license. It records what each company is looking to bring in, by therapeutic area, modality, indication, and development stage, along with contact details for the business development and external innovation people who handle those decisions.

Who uses it?

Technology transfer offices, small and mid-size biotech companies, and people in business development or R&D roles. It is most useful when you need companies and contacts in a specific therapeutic area or indication rather than a general industry list.

How current is the data?

The platform is updated weekly. Contact details are re-verified as people change roles and companies, and partnering interests are refreshed from our own meetings with the companies listed.

What does it cost?

Three annual plans, from 949 to 1,985 US dollars per team per year, each including 12 months of search access and a set number of credits. One credit unlocks one contact. Full pricing is on the pricing page.

Can I check that you cover my area before paying?

Yes. Request a free Partnering Snapshot and we will run a search on your therapeutic areas and send you a PDF showing how many companies match, broken down by region and company size.

Full FAQ. Last updated 2026-08-10.

See your coverage before you subscribe

Request a free snapshot and see how many companies match your focus. If the coverage is not there, we will tell you.

Get a free partnering snapshot See pricing